| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Coya Therapeutics, Inc.
13G
COYA · 22407B108
|
9.7% |
3/12/2026
Event 1/30/2026
|
||||
| Dr. Reddy's Laboratories, Inc. | 9.7% | |||||
| Dr. Reddy's Laboratories SA | 9.7% | |||||
| Dr. Reddy's Laboratories Limited | 9.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.